InvestorsHub Logo
Followers 67
Posts 4831
Boards Moderated 0
Alias Born 06/12/2014

Re: StockRoomBully post# 2

Thursday, 07/02/2020 9:01:49 AM

Thursday, July 02, 2020 9:01:49 AM

Post# of 110
Qualigen Therapeutics Receives U.S. Patent Notice of Allowance for its STARS™ Technology
June 4, 2020, 8:00 am
CARLSBAD, Calif., June 4, 2020 /PRNewswire/ -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued a Notice of Allowance for a U.S. patent, which will be issued to the Company, titled "Devices and Methods for On-Line Whole Blood Treatment" regarding the Company's Selective Target Antigen Removal System (STARS™) technology. STARS is a DNA/RNA-based treatment for the removal of viral and tumor-produced compounds from a patient's blood. The STARS technology utilizes a filtration cartridge designed for use in a standard dialysis machine, and contains aptamer-coated microparticles that bind to specific agents in circulating blood for targeted removal.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent QLGN News